Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 74


Metastasis predictive signature profiles pre-exist in normal tissues.

Yang H, Crawford N, Lukes L, Finney R, Lancaster M, Hunter KW.

Clin Exp Metastasis. 2005;22(7):593-603. Epub 2006 Feb 11.


Global expression profiling identifies signatures of tumor virulence in MMTV-PyMT-transgenic mice: correlation to human disease.

Qiu TH, Chandramouli GV, Hunter KW, Alkharouf NW, Green JE, Liu ET.

Cancer Res. 2004 Sep 1;64(17):5973-81.


Parallel analysis of transcript and translation profiles: identification of metastasis-related signal pathways differentially regulated by drug and genetic modifications.

Yang H, Yu LR, Yi M, Lucas DA, Lukes L, Lancaster M, Chan KC, Issaq HJ, Stephens RM, Conrads TP, Veenstra TD, Hunter KW.

J Proteome Res. 2006 Jul;5(7):1555-67.


The origins of breast cancer prognostic gene expression profiles.

Lukes L, Crawford NP, Walker R, Hunter KW.

Cancer Res. 2009 Jan 1;69(1):310-8. doi: 10.1158/0008-5472.CAN-08-3520.


Decreasing expression of NM23 gene in metastatic murine mammary tumors of viral etiology (MMTV).

Caligo MA, Cipollini G, Cope Di Valromita A, Bistocchi M, Bevilacqua G.

Anticancer Res. 1992 May-Jun;12(3):969-73.


Biomarkers of residual disease, disseminated tumor cells, and metastases in the MMTV-PyMT breast cancer model.

Franci C, Zhou J, Jiang Z, Modrusan Z, Good Z, Jackson E, Kouros-Mehr H.

PLoS One. 2013;8(3):e58183. doi: 10.1371/journal.pone.0058183. Epub 2013 Mar 8.


Predisposition to efficient mammary tumor metastatic progression is linked to the breast cancer metastasis suppressor gene Brms1.

Hunter KW, Broman KW, Voyer TL, Lukes L, Cozma D, Debies MT, Rouse J, Welch DR.

Cancer Res. 2001 Dec 15;61(24):8866-72.


Gene expression profiles of primary breast tumors maintained in distant metastases.

Weigelt B, Glas AM, Wessels LF, Witteveen AT, Peterse JL, van't Veer LJ.

Proc Natl Acad Sci U S A. 2003 Dec 23;100(26):15901-5. Epub 2003 Dec 9.


Genetic heterogeneity of Myc-induced mammary tumors reflecting diverse phenotypes including metastatic potential.

Andrechek ER, Cardiff RD, Chang JT, Gatza ML, Acharya CR, Potti A, Nevins JR.

Proc Natl Acad Sci U S A. 2009 Sep 22;106(38):16387-92. doi: 10.1073/pnas.0901250106. Epub 2009 Sep 4.


Distinct organ-specific metastatic potential of individual breast cancer cells and primary tumors.

Minn AJ, Kang Y, Serganova I, Gupta GP, Giri DD, Doubrovin M, Ponomarev V, Gerald WL, Blasberg R, Massagué J.

J Clin Invest. 2005 Jan;115(1):44-55.


Host genetics and tumour metastasis.

Hunter KW.

Br J Cancer. 2004 Feb 23;90(4):752-5. Review.


A mouse mammary gland involution mRNA signature identifies biological pathways potentially associated with breast cancer metastasis.

Stein T, Salomonis N, Nuyten DS, van de Vijver MJ, Gusterson BA.

J Mammary Gland Biol Neoplasia. 2009 Jun;14(2):99-116. doi: 10.1007/s10911-009-9120-1. Epub 2009 Apr 30. Review. Erratum in: J Mammary Gland Biol Neoplasia. 2009 Jun;14(2):117-9.


Fibronectin is distinctly downregulated in murine mammary adenocarcinoma cells with high metastatic potential.

Urtreger AJ, Werbajh SE, Verrecchia F, Mauviel A, Puricelli LI, Kornblihtt AR, Bal de Kier Joffé ED.

Oncol Rep. 2006 Dec;16(6):1403-10.


Gene signatures of progression and metastasis in renal cell cancer.

Jones J, Otu H, Spentzos D, Kolia S, Inan M, Beecken WD, Fellbaum C, Gu X, Joseph M, Pantuck AJ, Jonas D, Libermann TA.

Clin Cancer Res. 2005 Aug 15;11(16):5730-9.


A molecular signature of metastasis in primary solid tumors.

Ramaswamy S, Ross KN, Lander ES, Golub TR.

Nat Genet. 2003 Jan;33(1):49-54. Epub 2002 Dec 9.


Meta-analysis of multiple microarray datasets reveals a common gene signature of metastasis in solid tumors.

Daves MH, Hilsenbeck SG, Lau CC, Man TK.

BMC Med Genomics. 2011 Jul 7;4:56. doi: 10.1186/1755-8794-4-56.


A six-gene signature predicting breast cancer lung metastasis.

Landemaine T, Jackson A, Bellahcène A, Rucci N, Sin S, Abad BM, Sierra A, Boudinet A, Guinebretière JM, Ricevuto E, Noguès C, Briffod M, Bièche I, Cherel P, Garcia T, Castronovo V, Teti A, Lidereau R, Driouch K.

Cancer Res. 2008 Aug 1;68(15):6092-9. doi: 10.1158/0008-5472.CAN-08-0436.


Mena deficiency delays tumor progression and decreases metastasis in polyoma middle-T transgenic mouse mammary tumors.

Roussos ET, Wang Y, Wyckoff JB, Sellers RS, Wang W, Li J, Pollard JW, Gertler FB, Condeelis JS.

Breast Cancer Res. 2010;12(6):R101. doi: 10.1186/bcr2784. Epub 2010 Nov 25.

Supplemental Content

Support Center